Morgan Stanley’s Decoy Therapeutics DCOY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1
| Closed | -$7 | – | 8572 |
|
|
2026
Q1 | $7 | Buy |
+1
| New | +$9 | ﹤0.01% | 8228 |
|
|
2025
Q3 | – | Hold |
0
| – | -$6 | – | 8352 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 8042 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 8029 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7899 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7867 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7752 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7617 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7538 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7415 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7412 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7560 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7699 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7854 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7950 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7863 |
|
|
2021
Q4 | – | Sell |
-21
| Closed | -$556K | – | 7882 |
|
|
2021
Q3 | $775K | Buy |
21
+7
| +50% | +$242K | ﹤0.01% | 5220 |
|
|
2021
Q2 | $521K | Buy |
+14
| New | +$623K | ﹤0.01% | 5500 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7282 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6967 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6670 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6084 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6484 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6377 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6247 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6472 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6465 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6519 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6585 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6441 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6127 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6160 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6113 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6122 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 5682 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 5408 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 5517 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5213 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5314 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5514 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 5666 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5758 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5402 |
|
Other funds holding DCOY
Morgan Stanley's DCOY Position: Q2 2026 in Review
Morgan Stanley sold out of Decoy Therapeutics (DCOY) in Q2 2026, closing a stake of 1 share — an estimated $7 sold.
Morgan Stanley first reported a position in DCOY in Q2 2021 and held it in 3 quarters. The position peaked at $775K in Q3 2021. 4 funds tracked by Wall St. Rank hold DCOY as of Q2 2026.
- Morgan Stanley reported no remaining Decoy Therapeutics position as of Q2 2026 after selling out during the quarter.
- Morgan Stanley sold 1 Decoy Therapeutics share in Q2 2026, an estimated $7.
- Morgan Stanley first reported a position in Decoy Therapeutics in Q2 2021 and held it in 3 quarters.
- Morgan Stanley's Decoy Therapeutics position peaked at $775K in Q3 2021.
- 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.